The treatment of Caffeine Dependency & Cancer Risk Reduction with vitamins

Caffeine Dependency and Cancer Risk Reduction: Mitamins custom make quality formulas for the treatment of Caffeine Dependency & Cancer Risk Reduction with vitamins. A Caffeine Dependency & Cancer Risk Reduction formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Caffeine Dependency and Cancer Risk Reduction

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    CoQ-10
    25
    mg
    *
    Asian Ginseng Extract
    100
    mg
    *
    Eleuthero Extract
    100
    mg
    *
    Grape Seed Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Green Tea Extract
    50
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    L-Carnitine
    250
    mg
    *
    L-Tyrosine
    250
    mg
    *
    Ashwagandha Extract
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Caffeine Dependency and Cancer Risk Reduction
Monthly Cost: $43.55
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Caffeine Dependency and Cancer Risk Reduction Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Genmab Amends Ofatumumab Pivotal Study In NHL To Single Arm Study
Genmab A/S (OMX: GEN) announced it has amended the design of an ongoing pivotal study of ofatumumab (HuMax-CD20(R)) in rituximab refractory follicular non Hodgkin's lymphoma (NHL) to a single arm trial that will now include approximately 81 patients. All patients will receive one infusion of 300 mg of ofatumumab followed by 7 weekly infusions of 1000 mg of ofatumumab.
Early Immune Response In Lungs And Body Shut Down By Ozone
As policy makers debate what levels of ozone in the air are safe for humans to breathe, studies in mice are revealing that the inhaled pollutant impairs the body's first line of defense, making it more susceptible to subsequent foreign invaders, such as bacteria.
This information concerning the support of Caffeine Dependency and Cancer Risk Reduction treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Depression, Stress & Anxiety  Caffeine Dependency  Caffeine Dependency and Cancer Risk Reduction
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments